Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group.
Xu LP, Lu PH, Wu DP, Huang H, Jiang EL, Liu DH, Cao WJ, Zhang X, Fu YW, Li NN, Chen XC, Zhu XY, Liu QF, Xia LH, Zhang YC, Xu YJ, Li FC, Hu J, Liu SX, Liu RR, Ma XD, Tang XW, Luo Y, Zhang XH, Huang XJ; Chinese Blood and Marrow Transplantation Registry Group. Xu LP, et al. Among authors: xu yj. Bone Marrow Transplant. 2024 Sep 25. doi: 10.1038/s41409-024-02419-8. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39322652
Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study.
Huo MR, Xu YJ, Zhai SZ, Lv M, Wang Y, Cao LQ, Xu LP, Zhang XH, Chen H, Chen YH, Wang FR, Han W, Sun YQ, Yan CH, Tang FF, Mo XD, Zhao MF, Liu KY, Huang XJ, Chang YJ. Huo MR, et al. Among authors: xu yj, xu lp. Hum Immunol. 2018 Sep;79(9):672-677. doi: 10.1016/j.humimm.2018.06.003. Epub 2018 Jun 8. Hum Immunol. 2018. PMID: 29890181 Free article.
Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG).
Tang F, Xu Y, Chen H, Xu L, Zhang X, Wang Y, Liu Q, Wu D, Huang X. Tang F, et al. Sci China Life Sci. 2020 Apr;63(4):571-581. doi: 10.1007/s11427-019-9594-7. Epub 2019 Aug 14. Sci China Life Sci. 2020. PMID: 31420852
Haploidentical hematopoietic cell transplantation for severe acquired aplastic anemia: a case-control study of post-transplant cyclophosphamide included regimen vs. anti-thymocyte globulin & colony-stimulating factor-based regimen.
Xu L, Fu B, Wang W, Xu Y, Wu D, Wang S, Liu Q, Xia L, Gao S, Jiang M, Wang J, Zhang X, Bai H, Chen H, Li C, Huang X. Xu L, et al. Sci China Life Sci. 2020 Jun;63(6):940-942. doi: 10.1007/s11427-019-9585-x. Epub 2019 Aug 14. Sci China Life Sci. 2020. PMID: 31428917 No abstract available.
Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study.
Yu S, Huang F, Wang Y, Xu Y, Yang T, Fan Z, Lin R, Xu N, Xuan L, Ye J, Yu W, Sun J, Huang X, Liu Q. Yu S, et al. Leukemia. 2020 May;34(5):1433-1443. doi: 10.1038/s41375-019-0686-3. Epub 2019 Dec 12. Leukemia. 2020. PMID: 31831845 Clinical Trial.
Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data.
Yu S, Huang F, Fan Z, Xuan L, Nie D, Xu Y, Yang T, Wang S, Jiang Z, Xu N, Lin R, Ye J, Lin D, Sun J, Huang X, Wang Y, Liu Q. Yu S, et al. J Hematol Oncol. 2020 Mar 12;13(1):18. doi: 10.1186/s13045-020-00859-5. J Hematol Oncol. 2020. PMID: 32164760 Free PMC article. Clinical Trial.
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.
Xuan L, Wang Y, Huang F, Fan Z, Xu Y, Sun J, Xu N, Deng L, Li X, Liang X, Luo X, Shi P, Liu H, Wang Z, Jiang L, Yu C, Zhou X, Lin R, Chen Y, Tu S, Huang X, Liu Q. Xuan L, et al. Lancet Oncol. 2020 Sep;21(9):1201-1212. doi: 10.1016/S1470-2045(20)30455-1. Epub 2020 Aug 10. Lancet Oncol. 2020. PMID: 32791048 Clinical Trial.
Haploidentical transplantation has a superior graft-versus-leukemia effect than HLA-matched sibling transplantation for Ph- high-risk B-cell acute lymphoblastic leukemia.
Fan M, Wang Y, Lin R, Lin T, Huang F, Fan Z, Xu Y, Yang T, Xu N, Shi P, Nie D, Lin D, Jiang Z, Wang S, Sun J, Huang X, Liu Q, Xuan L. Fan M, et al. Chin Med J (Engl). 2022 Apr 20;135(8):930-939. doi: 10.1097/CM9.0000000000001852. Chin Med J (Engl). 2022. PMID: 35467818 Free PMC article.
1,428 results